Publicacións en colaboración con investigadores/as de Institut d'Investigació Biomédica de Bellvitge (7)

2024

  1. Validation of ZIP4 as a tumour-associated antigen for nanotargeting

    Journal of Drug Targeting

2023

  1. Gal-1 Expression Analysis in the GLIOCAT Multicenter Study: Role as a Prognostic Factor and an Immune-Suppressive Biomarker

    Cells, Vol. 12, Núm. 6

  2. Long-term platinum-based drug accumulation in cancer-associated fibroblasts promotes colorectal cancer progression and resistance to therapy

    Nature communications, Vol. 14, Núm. 1, pp. 746

2022

  1. Distinct roles for PARP-1 and PARP-2 in c-Myc–driven B-cell lymphoma in mice

    Blood, Vol. 139, Núm. 2, pp. 228-239

  2. Exploring the Role of Galectins in Cancer : In Vitro and In Vivo Approaches

    Methods in Molecular Biology (Humana Press Inc.), pp. 685-711

  3. Sialyltransferase Inhibitor Ac53FaxNeu5Ac Reverts the Malignant Phenotype of Pancreatic Cancer Cells, and Reduces Tumor Volume and Favors T-Cell Infiltrates in Mice

    Cancers, Vol. 14, Núm. 24

2020

  1. Knockdown of α2,3-sialyltransferases impairs pancreatic cancer cell migration, invasion and e-selectin-dependent adhesion

    International Journal of Molecular Sciences, Vol. 21, Núm. 17, pp. 1-24